Akèy › Gliyoblastòm › Nebraska › Omaha
Etid klinik pou Gliyoblastòm nan Omaha, NE
4 etid pou Gliyoblastòm ap chèche patisipan nan sit nan ak bò kote Omaha (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Ap rekriteFaz 2
- University of Nebraska Medical Center, Omaha
A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Ap rekriteFaz 1
- University of Nebraska Medical Center, Omaha
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Ap rekriteFaz 1
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Omaha
Etid Gliyoblastòm nan lòt vil
- New York City, NY30 etid
- Boston, MA28 etid
- Houston, TX26 etid
- Los Angeles, CA24 etid
- Durham, NC20 etid
- San Francisco, CA17 etid
- Chicago, IL15 etid
- Washington, DC15 etid
- Columbus, OH14 etid
- Miami, FL14 etid
- Rochester, MN13 etid
- Jacksonville, FL13 etid
Lòt etid nan Omaha
- Kansè pwostat27 etid
- Kansè Poumon ki pa ti selil24 etid
- Kansè nan tete22 etid
- Kansè (tout kalite)18 etid
- Kansè kolorektal18 etid
- Myelom Miltip16 etid
- Kansè ovè14 etid
- Limfòm Non-Hodgkin14 etid
- Kansè pankreyas14 etid
- Kansè Metastatik13 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Ensifizyans kadyak13 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.